Van Eck Associates Corp Bristol Myers Squibb CO Transaction History
Van Eck Associates Corp
- $78.1 Billion
- Q4 2024
A detailed history of Van Eck Associates Corp transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Van Eck Associates Corp holds 9,069,826 shares of BMY stock, worth $506 Million. This represents 0.66% of its overall portfolio holdings.
Number of Shares
9,069,826
Previous 9,933,591
8.7%
Holding current value
$506 Million
Previous $527 Million
2.67%
% of portfolio
0.66%
Previous 0.66%
Shares
31 transactions
Others Institutions Holding BMY
# of Institutions
2,751Shares Held
1.57BCall Options Held
28MPut Options Held
28.7M-
Vanguard Group Inc Valley Forge, PA190MShares$10.6 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.86 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY96MShares$5.36 Billion0.44% of portfolio
-
State Street Corp Boston, MA95.1MShares$5.31 Billion0.22% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.37 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $119B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...